1. Abdolmaleki F., Kovanen P.T., Mardani R., Gheibi-Hayat S.M., BoS., Sahebkar A.: Resolvins: Emerging players in autoimmune andinflammatory diseases. Clin. Rev. Allergy Immunol., 2020; 58: 82–91 2 Bautista D., Obrador A., Moreno V., Cabeza E., Canet R., BenitoE., Bosh X., Costa J.: Ki-ras mutation modifies the protective effectof dietary monounsaturated fat and calcium on sporadic colorectalcancer. Cancer Epidemiol. Biomarkers Prev., 1997; 6: 57–61
2. represses gene expression: Evidence of role inacute-phase inflammatory response. Arterioscler. Thromb. Vasc.Biol., 2002; 22: 1631–1636
3. Brink M., Weijenberg M.P., De Goeij A.F., Schouten L.J., KoedijkF.D., Roemen G.M., Lentjes M.H., De Bruïne A.P., Goldbohm R.A.,Van Den Brandt P.A.: Fat and K-ras mutations in sporadic colorectalcancer in The Netherlands Cohort Study. Carcinogenesis,2004; 25: 1619–1628
4. Broughton K.S., Johnson C.S., Pace B.K., Liebman M., KleppingerK.M.: Reduced asthma symptoms with n-3 fatty acid ingestion arerelated to 5-series leukotriene production. Am. J. Clin. Nutr., 1997;65: 1011–1017
5. Burdan F., Chałas A., Szumiło J.: Cyclooxygenase and prostanoids– biological implications. Postępy Hig. Med. Dośw., 2006;60: 129–141